PL2416770T3 - Roztwory do hemodializy i dializy otrzewnowej zawierające jeden lub więcej związków kreatyny - Google Patents

Roztwory do hemodializy i dializy otrzewnowej zawierające jeden lub więcej związków kreatyny

Info

Publication number
PL2416770T3
PL2416770T3 PL10707804T PL10707804T PL2416770T3 PL 2416770 T3 PL2416770 T3 PL 2416770T3 PL 10707804 T PL10707804 T PL 10707804T PL 10707804 T PL10707804 T PL 10707804T PL 2416770 T3 PL2416770 T3 PL 2416770T3
Authority
PL
Poland
Prior art keywords
hemodialysis
peritoneal dialysis
dialysis solutions
creatine compounds
creatine
Prior art date
Application number
PL10707804T
Other languages
English (en)
Inventor
Michael Möddel
Theo Wallimann
Original Assignee
Crearene Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crearene Ltd. filed Critical Crearene Ltd.
Publication of PL2416770T3 publication Critical patent/PL2416770T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL10707804T 2009-04-06 2010-03-10 Roztwory do hemodializy i dializy otrzewnowej zawierające jeden lub więcej związków kreatyny PL2416770T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09005038 2009-04-06
EP10707804.0A EP2416770B1 (en) 2009-04-06 2010-03-10 Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds

Publications (1)

Publication Number Publication Date
PL2416770T3 true PL2416770T3 (pl) 2017-06-30

Family

ID=42111284

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10707804T PL2416770T3 (pl) 2009-04-06 2010-03-10 Roztwory do hemodializy i dializy otrzewnowej zawierające jeden lub więcej związków kreatyny

Country Status (13)

Country Link
US (2) US9248112B2 (pl)
EP (1) EP2416770B1 (pl)
JP (1) JP6130666B2 (pl)
CN (1) CN102421431B (pl)
AU (1) AU2010234206B2 (pl)
BR (1) BRPI1006260B8 (pl)
CA (1) CA2757327C (pl)
EA (1) EA025137B1 (pl)
ES (1) ES2615204T3 (pl)
IL (1) IL215504A (pl)
PL (1) PL2416770T3 (pl)
WO (1) WO2010115291A1 (pl)
ZA (1) ZA201107715B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012001320B1 (pt) 2009-07-24 2021-10-05 Crearene Ag Solução de diálise, kit configurado para preparação de uma solução de diálise e preparação sólida
ES2382513B2 (es) * 2012-05-07 2012-09-24 Luiz Guilherme STARK AROEIRA Solución de diálisis que contiene al menos un antagonista de CCR2
CN102973599B (zh) * 2012-12-13 2014-04-23 天津金耀集团有限公司 腹膜透析液(乳酸盐)组合物
ES2875060T3 (es) 2013-06-07 2021-11-08 Allena Pharmaceuticals Inc Composiciones y dispositivos para diálisis
WO2017084682A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal carbon dioxide removal
WO2017084683A1 (en) 2015-11-20 2017-05-26 Hepa Wash Gmbh Method for extracorporeal lung support
RU2729725C2 (ru) 2016-03-14 2020-08-11 Хепа Уош Гмбх Системы или устройства и способы проведения диализа
NZ750126A (en) * 2016-08-11 2022-07-01 Cellix Bio Private Ltd Compositions and methods for the treatment of irritable bowel syndrome
US20210100941A1 (en) * 2017-03-28 2021-04-08 Advitos Gmbh Compositions and methods for regenerating carrier protein-containing multiple pass albumin dialysis fluid
AU2018273106A1 (en) 2017-05-22 2019-12-19 Advitos Gmbh Methods and systems for removing carbon dioxide
CN111902150B (zh) * 2017-10-20 2024-04-02 乔治亚大学研究基金公司 具有防污、抗血栓形成和抗菌性质的表面和涂层组合物及制备方法
CN107890568A (zh) * 2017-10-31 2018-04-10 华仁药业股份有限公司 一种低危害的血液滤过置换液及其制备工艺
KR101864384B1 (ko) * 2017-12-11 2018-06-04 (주)나노스템 콜린 알포세레이트를 유효성분으로 하는 쥐남의 치료, 개선 또는 예방용 조성물 및 방법
GB201801633D0 (en) * 2018-02-01 2018-03-21 Ogorman Edward Sports supplements based on liquid creatine
KR102683836B1 (ko) 2018-10-11 2024-07-09 사니핏 테라퓨틱스 에스.에이. 이소성 석회화의 치료를 위한 이노시톨 포스페이트
CN114903998A (zh) * 2021-02-07 2022-08-16 大连医科大学附属第二医院 渗透压保护防治腹膜纤维化和超滤衰竭

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604379A (en) * 1984-06-18 1986-08-05 Curators Of The University Of Missouri Dialysis solutions containing cross-linked gelatin
FR2614219B1 (fr) * 1987-04-23 1993-07-09 Materiels Annexes Dialyse Procede de fabrication de granules destines a la preparation de solutions de dialyse et installation pour sa mise en oeuvre.
US5827820A (en) * 1992-04-06 1998-10-27 Baxter International Inc. Aqueous peritoneal dialysis solution
ATE332127T1 (de) 1994-11-08 2006-07-15 Avicena Group Inc Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
JPH11513671A (ja) 1995-10-11 1999-11-24 アヴィセナ グループ,インク. 糖代謝異常の治療のためのクレアチン類似体の利用
DE69940525D1 (de) * 1999-05-11 2009-04-16 Cellfree Sciences Co Ltd Zubereitung, die einen zellextrakt zur herstellung eines zellfreien proteins enthalten und vorrichtung zur herstellung eines zellfreien proteins
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
WO2001000212A1 (en) 1999-06-25 2001-01-04 Avicena Group, Inc. Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
EP1567180A4 (en) 2002-06-04 2010-03-10 Avicena Group Inc METHODS OF TREATING COGNITIVE DYSFUNCTIONS BY MODULATING BRAIN ENERGY METABOLISM
AU2007249811A1 (en) 2006-05-11 2007-11-22 Avicena Group, Inc. Creatine-ligand compounds and methods of use thereof
EP2468272A1 (en) 2006-05-11 2012-06-27 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
DE102006050931A1 (de) * 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
AU2007332800A1 (en) 2006-12-07 2008-06-19 Avicena Group, Inc. Creatine compositions for skin treatment
US20090005450A1 (en) 2007-04-09 2009-01-01 Belinda Tsao Nivaggioli Use of creatine compounds for the treatment of eye disorders
WO2008137137A1 (en) 2007-05-03 2008-11-13 Avicena Group, Inc. Creatine ascorbyl derivatives and methods of use thereof
WO2009002913A1 (en) 2007-06-22 2008-12-31 Avicena Group, Inc. Use of creatine compounds to treat dermatitis

Also Published As

Publication number Publication date
JP2012522812A (ja) 2012-09-27
IL215504A (en) 2017-04-30
ZA201107715B (en) 2012-07-25
EP2416770B1 (en) 2016-10-26
AU2010234206A1 (en) 2011-11-03
BRPI1006260A2 (pt) 2017-01-17
BRPI1006260B8 (pt) 2021-05-25
EA201101463A1 (ru) 2012-03-30
CN102421431A (zh) 2012-04-18
US9248112B2 (en) 2016-02-02
WO2010115291A1 (en) 2010-10-14
CA2757327A1 (en) 2010-10-14
IL215504A0 (en) 2011-12-29
EP2416770A1 (en) 2012-02-15
CN102421431B (zh) 2019-04-02
AU2010234206A2 (en) 2011-11-10
US20160120829A1 (en) 2016-05-05
CA2757327C (en) 2017-12-12
BRPI1006260B1 (pt) 2020-11-17
US20120101069A1 (en) 2012-04-26
JP6130666B2 (ja) 2017-05-17
ES2615204T3 (es) 2017-06-05
AU2010234206B2 (en) 2016-10-27
HK1164157A1 (en) 2012-09-21
EA025137B1 (ru) 2016-11-30

Similar Documents

Publication Publication Date Title
IL215504A0 (en) Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
EP2569029A4 (en) SYSTEMS AND METHOD FOR IMPROVED STERILIZATION DURING A PERITONEAL DIALYSIS
GB2469950B (en) Dialysis system with recirculating dialysis fluid
GB2503162B (en) Peritoneal dialysis systems and devices
BRPI0721897A2 (pt) Dialisado peritoneal
PL2211874T3 (pl) Sterylizowane roztwory dializacyjne zawierające pirofosforan
EP2327430A4 (en) INFUSION PUMP SYSTEM
WO2008106191A8 (en) Hemodialysis systems and methods
EP2594300A4 (en) hemodialysis
EP2576024A4 (en) Dialysis system
GB0806378D0 (en) Subcutaneous port and catheter
PL2531531T3 (pl) Rozgałęzione rozpuszczalne polimery glukozy do dializy otrzewnowej
PL2424899T3 (pl) Sposób oczyszczania polimerów glukozy do roztworów do dializy otrzewnowej
EP2151247A4 (en) PREPARATION OF SOLID DIALYSIS
AU304281S (en) Peritoneal dialysis cycler
PL2585076T3 (pl) Kompozycja prekursora do dializy
GB0802169D0 (en) Extracorporeal membrane oxygenation
GB0608444D0 (en) Dialysis
PL1744768T3 (pl) Roztwór do dializy otrzewnowej
GB0816883D0 (en) Rotary blood pump
EP1890686A4 (en) peritoneal
GB0806172D0 (en) Fluid treatment system
PL2456431T3 (pl) Roztwór dializacyjny zawierający kreatynę do ochrony komórek
PL1858504T3 (pl) Roztwór do dializy otrzewnowej zawierający karnitynę, o poprawionej biokompatybilności
IL195134A0 (en) A blood transfusion set